Vaccine immunotherapy for prostate cancer: from mice to men.

Abstract

Preclinical studies demonstrated the ability of an adenovirus/PSA (Ad/PSA) vaccine to induce strong anti-PSA immune responses, and these responses were capable of destroying prostate-specific antigen (PSA)-secreting mouse prostate tumors. A series of preclinical studies have demonstrated the superiority of the Ad/PSA vaccine to other PSA vaccines for the… (More)
DOI: 10.1007/s12026-014-8531-2

Topics

  • Presentations referencing similar topics